MapLight Therapeutics, Inc. logo

MapLight Therapeutics, Inc. (MPLT) Q4 2025 Annual Earnings

MPLT·Reported May 14, 2026·Before market open

Diluted EPS came in at $-1.34, missed the $-0.96 consensus by $0.38.

Diluted EPS
$-1.34missed by $0.38
Consensus: $-0.96
SEC

SEC Filings

Earnings release8-K · 0001193125-26-224067
Annual report10-K · 0001193125-26-125072

Financial Snapshot

Trailing eight quarters through Q4 2025

View all metrics

Q4 2025 Earnings FAQ

Common questions about MapLight Therapeutics, Inc. 's Q4 2025 earnings report.

MapLight Therapeutics, Inc. (MPLT) reported Q4 2025 earnings on May 14, 2026 before market open.

MapLight Therapeutics, Inc. reported diluted EPS of $-1.34 for Q4 2025.

EPS missed the consensus estimate of $-0.96 by $0.38.

You can read the 8-K earnings release (0001193125-26-224067) and the 10-K periodic report (0001193125-26-125072) directly on SEC EDGAR. The filing index links above go to sec.gov.